Citadel Advisors’s Meta Materials Inc. Common Stock MMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,776
Closed -$11.7K 15664
2023
Q4
$11.7K Sell
1,776
-100
-5% -$1.2K ﹤0.01% 13030
2023
Q3
$39.8K Sell
1,876
-1,076
-36% -$23.6K ﹤0.01% 12000
2023
Q2
$63.5K Sell
2,952
-2,460
-45% -$59.2K ﹤0.01% 11519
2023
Q1
$221K Buy
5,412
+3,125
+137% +$243K ﹤0.01% 10009
2022
Q4
$272K Sell
2,287
-14
-0.6% -$1.85K ﹤0.01% 9527
2022
Q3
$149K Buy
2,301
+444
+24% +$38.9K ﹤0.01% 10708
2022
Q2
$191K Buy
1,857
+574
+45% +$85.7K ﹤0.01% 10746
2022
Q1
$214K Buy
1,283
+210
+20% +$39.1K ﹤0.01% 11364
2021
Q4
$264K Sell
1,073
-500
-32% -$206K ﹤0.01% 11220
2021
Q3
$909K Buy
1,573
+638
+68% +$278K ﹤0.01% 8402
2021
Q2
$700K Buy
+935
New +$522K ﹤0.01% 9246

Other funds holding MMAT

Citadel Advisors's MMAT Position: Q1 2024 in Review

Citadel Advisors sold out of Meta Materials Inc. Common Stock (MMAT) in Q1 2024, closing a stake of 1,304 shares — an estimated $8.6K sold.

Citadel Advisors first reported a position in MMAT in Q4 2014 and held it in 19 quarters. The position peaked at $5.03M in Q4 2021. 29 funds tracked by Wall St. Rank hold MMAT as of Q1 2024.

  • Citadel Advisors reported no remaining Meta Materials Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,304 Meta Materials Inc. Common Stock shares in Q1 2024, an estimated $8.6K.
  • Citadel Advisors first reported a position in Meta Materials Inc. Common Stock in Q4 2014 and held it in 19 quarters.
  • Citadel Advisors's Meta Materials Inc. Common Stock position peaked at $5.03M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Meta Materials Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.